Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases

NeuroMolecular Medicine

Volumn 10, Issue 4, 2008, Pages 275-290

  Adhihetty, Peter J ^a   Beal, M Flint ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Alzheimer's; Amyotrophic lateral sclerosis; Apoptosis; Bioenergetics; Huntington's; Mitochondria; Parkinson's; Reactive oxygen species

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CREATINE; CREATINE PHOSPHATE; REACTIVE OXYGEN METABOLITE; ADENOSINE TRIPHOSPHATE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN MITOCHONDRION; CELL ENERGY; CLINICAL TRIAL; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DRUG EFFICACY; HUMAN; HUNTINGTON CHOREA; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; ANIMAL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; ENERGY METABOLISM; METABOLISM; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; ANIMALS; CREATINE; DIETARY SUPPLEMENTS; ENERGY METABOLISM; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; NEURODEGENERATIVE DISEASES; PHOSPHOCREATINE;

EID: 65249129156     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12017-008-8053-y     Document Type: Review

References (117)

1. JM Adams S Cory 1998 The Bcl-2 protein family: Arbiters of cell survival Science 281 1322 1326 10.1126/science.281.5381.1322 (Pubitemid 28406819)
2. PJ Adhihetty DA Hood 2003 Mechanisms of apoptosis in skeletal muscle Basic and Applied Myology 13 171 179
3. PJ Adhihetty I Irrcher AM Joseph V Ljubicic DA Hood 2003 Plasticity of skeletal muscle mitochondria in response to contractile activity Experimental Physiology 88 99 107 10.1113/eph8802505
4. M Aksenov M Aksenova DA Butterfield WR Markesbery 2000 Oxidative modification of creatine kinase BB in Alzheimer's disease brain Journal of Neurochemistry 74 2520 2527 10.1046/j.1471-4159.2000.0742520.x
5. TA Alston L Mela HJ Bright 1977 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase Proceedings of the National Academy of Sciences of the United States of America 74 3767 3771 10.1073/pnas.74.9.3767
6. OA Andreassen A Dedeoglu RJ Ferrante BG Jenkins KL Ferrante M Thomas A Friedlich SE Browne G Schilling DR Borchelt SM Hersch CA Ross MF Beal 2001 Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease Neurobiology of Disease 8 479 491 10.1006/nbdi.2001.0406
7. RH Andres AD Ducray U Schlattner T Wallimann HR Widmer 2008 Functions and effects of creatine in the central nervous system Brain Research Bulletin 76 329 343 10.1016/j.brainresbull.2008.02.035
8. CP Baines RA Kaiser NH Purcell NS Blair H Osinska MA Hambleton EW Brunskill MR Sayen RA Gottlieb GW Dorn J Robbins JD Molkentin 2005 Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death Nature 434 658 662 10.1038/nature03434
9. SK Baker MA Tarnopolsky 2003 Targeting cellular energy production in neurological disorders Expert Opinion on Investigational Drugs 12 1655 1679 10.1517/13543784.12.10.1655
10. MF Beal E Brouillet BG Jenkins RJ Ferrante NW Kowall JM Miller E Storey R Srivastava BR Rosen BT Hyman 1993 Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid Journal of Neuroscience 13 4181 4192 (Pubitemid 23299942)
11. MF Beal 1995 Aging, energy, and oxidative stress in neurodegenerative diseases Annals of Neurology 38 357 366 10.1002/ana.410380304
12. MF Beal 1996 Mitochondria, free radicals, and neurodegeneration Current Opinion in Neurobiology 6 661 666 10.1016/S0959-4388(96)80100-0
13. MF Beal 2000 Mitochondria and the pathogenesis of ALS Brain 123 Pt 7 1291 1292 10.1093/brain/123.7.1291 (Pubitemid 30420932)
14. MF Beal 2000 Energetics in the pathogenesis of neurodegenerative diseases Trends in Neurosciences 23 298 304 10.1016/S0166-2236(00)01584-8
15. MF Beal 2000 Limited-time exposure to mitochondrial toxins may lead to chronic progressive neurodegenerative diseases Movement Disorders 15 434 435 10.1002/1531-8257(200005)15:3<434::AID-MDS1002>3.0.CO;2-Q
16. MF Beal 2003 Bioenergetic approaches for neuroprotection in Parkinson's disease Annals of Neurology 53 Suppl 3 S39 S47 10.1002/ana.10479
17. MF Beal RJ Ferrante 2004 Experimental therapeutics in transgenic mouse models of Huntington's disease Nature Reviews. Neuroscience 5 373 384 10.1038/nrn1386 (Pubitemid 38568498)
18. G Benzi A Ceci 2001 Creatine as nutritional supplementation and medicinal product Journal of Sports Medicine and Physical Fitness 41 1 10 (Pubitemid 32367396)
19. SP Bessman PJ Geiger 1981 Transport of energy in muscle: The phosphorylcreatine shuttle Science 211 448 452 10.1126/science.6450446 (Pubitemid 11145312)
20. LA Bindoff M Birch-Machin NE Cartlidge WD Parker Jr DM Turnbull 1989 Mitochondrial function in Parkinson's disease Lancet 2 49 10.1016/S0140-6736(89) 90291-2 (Pubitemid 19158192)
21. J Boero W Qin J Cheng TA Woolsey AW Strauss Z Khuchua 2003 Restricted neuronal expression of ubiquitous mitochondrial creatine kinase: Changing patterns in development and with increased activity Molecular and Cellular Biochemistry 244 69 76 10.1023/A:1022409101641
22. MB Bogdanov RJ Ferrante S Kuemmerle P Klivenyi MF Beal 1998 Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease Journal of Neurochemistry 71 2642 2644 (Pubitemid 28531279)
23. MB Bogdanov LE Ramos Z Xu MF Beal 1998 Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis Journal of Neurochemistry 71 1321 1324 (Pubitemid 28390288)
24. GJ Brewer TW Wallimann 2000 Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons Journal of Neurochemistry 74 1968 1978 10.1046/j.1471-4159.2000.0741968. x
25. E Brouillet BG Jenkins BT Hyman RJ Ferrante NW Kowall R Srivastava DS Roy BR Rosen MF Beal 1993 Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid Journal of Neurochemistry 60 356 359 10.1111/j.1471-4159.1993.tb05859.x
26. E Brouillet P Hantraye RJ Ferrante R Dolan A Leroy-Willig NW Kowall MF Beal 1995 Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates Proceedings of the National Academy of Sciences of the United States of America 92 7105 7109 10.1073/pnas.92.15.7105
27. SE Browne AC Bowling U MacGarvey MJ Baik SC Berger MM Muqit ED Bird MF Beal 1997 Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia Annals of Neurology 41 646 653 10.1002/ana.410410514
28. SE Browne RJ Ferrante MF Beal 1999 Oxidative stress in Huntington's disease Brain Pathology 9 147 163 (Pubitemid 29056525)
29. TS Burklen U Schlattner R Homayouni K Gough M Rak A Szeghalmi T Wallimann 2006 The creatine kinase/creatine connection to Alzheimer's disease: CK-inactivation, APP-CK complexes and focal creatine deposits Journal of Biomedicine and Biotechnology 2006 35936 10.1155/JBB/2006/35936
30. DA Butterfield CM Lauderback 2002 Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress Free Radical Biology and Medicine 32 1050 1060 10.1016/S0891-5849(02)00794-3
31. E Candlish CJ La AM Unrau 1969 The biosynthesis of 3-nitropropionic acid in creeping indigo (Indigofera spicata) Biochemistry 8 182 186 10.1021/bi00829a026
32. + concentration in transfected neuroblastoma SH-SY5Y cells FEBS Letters 414 365 368 10.1016/S0014-5793(97)01051-X
33. A Castegna M Aksenov V Thongboonkerd JB Klein WM Pierce R Booze WR Markesbery DA Butterfield 2002 Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: Dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71 Journal of Neurochemistry 82 1524 1532 10.1046/j.1471-4159.2002.01103.x
34. A Castegna M Aksenov M Aksenova V Thongboonkerd JB Klein WM Pierce R Booze WR Markesbery DA Butterfield 2002 Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1 Free Radical Biology and Medicine 33 562 571 10.1016/S0891-5849(02)00914-0
35. RB Ceddia G Sweeney 2004 Creatine supplementation increases glucose oxidation and AMPK phosphorylation and reduces lactate production in L6 rat skeletal muscle cells Journal of Physiology 555 409 421 (Pubitemid 38380000)
36. K Csukly A Ascah J Matas PF Gardiner E Fontaine Y Burelle 2006 Muscle denervation promotes opening of the permeability transition pore and increases the expression of cyclophilin D Journal of Physiology 574 319 327 10.1113/jphysiol.2006.109702
37. L Cui H Jeong F Borovecki CN Parkhurst N Tanese D Krainc 2006 Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration Cell 127 59 69 10.1016/j.cell.2006.09.015
38. S David M Shoemaker BE Haley 1998 Abnormal properties of creatine kinase in Alzheimer's disease brain: Correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning Brain Research. Molecular Brain Research 54 276 287 10.1016/S0169-328X(97)00343-4
39. SM de la Monte T Luong TR Neely D Robinson JR Wands 2000 Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease Laboratory Investigation 80 1323 1335 10.1038/labinvest.3780140 (Pubitemid 30637072)
40. A Dedeoglu JK Kubilus L Yang KL Ferrante SM Hersch MF Beal RJ Ferrante 2003 Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice Journal of Neurochemistry 85 1359 1367 10.1046/j.1471-4159.2003.01706.x
41. F Di Lisa P Bernardi 2006 Mitochondria and ischemia-reperfusion injury of the heart: Fixing a hole Cardiovascular Research 70 191 199 10.1016/j.cardiores.2006.01.016
42. M Dolder O Walzel U Speer T Schlattner T Wallimann 2003 Inhibition of the mitochondrial transition by creatine kinase substrates. Requirement for microcompartmentation Journal of Biological Chemistry 278 17760 17766 10.1074/jbc.M208705200
43. HM Eppenberger DM Dawson NO Kaplan 1967 The comparative enzymology of creatine kinases. I. Isolation and characterization from chicken and rabbit tissues Journal of Biological Chemistry 242 204 209
44. RJ Ferrante OA Andreassen BG Jenkins A Dedeoglu S Kuemmerle JK Kubilus R Kaddurah-Daouk SM Hersch MF Beal 2000 Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease Journal of Neuroscience 20 4389 4397 (Pubitemid 30396603)
45. M Gallant M Rak A Szeghalmi MR Del Bigio D Westaway J Yang R Julian KM Gough 2006 Focally elevated creatine detected in amyloid precursor protein (APP) transgenic mice and Alzheimer disease brain tissue Journal of Biological Chemistry 281 5 8 10.1074/jbc.C500244200
46. DR Green JC Reed 1998 Mitochondria and apoptosis Science 281 1309 1312 10.1126/science.281.5381.1309 (Pubitemid 28406816)
47. GJ Groeneveld HJ Van Kan S Kalmijn JH Veldink HJ Guchelaar JH Wokke LH van den Berg 2003 Riluzole serum concentrations in patients with ALS: Associations with side effects and symptoms Neurology 61 1141 1143 (Pubitemid 37461957)
48. T Grunewald MF Beal 1999 Bioenergetics in Huntington's disease Annals of the New York Academy of Sciences 893 203 213 10.1111/j.1749-6632.1999.tb07827.x (Pubitemid 30038077)
49. M Gu MT Gash VM Mann F Javoy-Agid JM Cooper AH Schapira 1996 Mitochondrial defect in Huntington's disease caudate nucleus Annals of Neurology 39 385 389 10.1002/ana.410390317
50. ME Gurney H Pu AY Chiu MC Dal Canto CY Polchow DD Alexander J Caliendo A Hentati YW Kwon HX Deng 1994 Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation Science 264 1772 1775 10.1126/science.8209258 (Pubitemid 24227760)
51. R Henshaw BG Jenkins JB Schulz RJ Ferrante NW Kowall BR Rosen MF Beal 1994 Malonate produces striatal lesions by indirect NMDA receptor activation Brain Research 647 161 166 10.1016/0006-8993(94)91412-5
52. K Hensley DA Butterfield M Mattson M Aksenova M Harris JF Wu R Floyd J Carney 1995 A model for beta-amyloid aggregation and neurotoxicity based on the free radical generating capacity of the peptide: Implications of "molecular shrapnel" for Alzheimer's disease Proceedings of the Western Pharmacology Society 38 113 120
53. SM Hersch S Gevorkian K Marder C Moskowitz A Feigin M Cox P Como C Zimmerman M Lin L Zhang AM Ulug MF Beal W Matson M Bogdanov E Ebbel A Zaleta Y Kaneko B Jenkins N Hevelone H Zhang H Yu D Schoenfeld R Ferrante HD Rosas 2006 Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG Neurology 66 250 252 10.1212/01.wnl.0000194318.74946.b6
54. I Hervias MF Beal G Manfredi 2006 Mitochondrial dysfunction and amyotrophic lateral sclerosis Muscle and Nerve 33 598 608 10.1002/mus.20489
55. S Hoyer 2004 Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: Therapeutic implications Advances in Experimental Medicine and Biology 541 135 152
56. WE Jacobus AL Lehninger 1973 Creatine kinase of rat heart mitochondria. Coupling of creatine phosphorylation to electron transport Journal of Biological Chemistry 248 4803 4810
57. BG Jenkins WJ Koroshetz MF Beal BR Rosen 1993 Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy Neurology 43 2689 2695 (Pubitemid 24004570)
58. CR Jost CE Van Der Zee HJ In't Zandt F Oerlemans M Verheij F Streijger J Fransen A Heerschap AR Cools B Wieringa 2002 Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility European Journal of Neuroscience 15 1692 1706 (Pubitemid 35471925)
59. MS Juhn M Tarnopolsky 1998 Oral creatine supplementation and athletic performance: A critical review Clinical Journal of Sport Medicine 8 286 297 (Pubitemid 29022831)
60. MS Juhn M Tarnopolsky 1998 Potential side effects of oral creatine supplementation: A critical review Clinical Journal of Sport Medicine 8 298 304 (Pubitemid 29022832)
61. P Klivenyi RJ Ferrante RT Matthews MB Bogdanov AM Klein OA Andreassen G Mueller M Wermer R Kaddurah-Daouk MF Beal 1999 Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis Nature Medicine 5 347 350 10.1038/6568
62. JE Kokoszka KG Waymire SE Levy JE Sligh J Cai DP Jones GR MacGregor DC Wallace 2004 The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore Nature 427 461 465 10.1038/nature02229
63. WJ Koroshetz BG Jenkins BR Rosen MF Beal 1997 Energy metabolism defects in Huntington's disease and effects of coenzyme Q10 Annals of Neurology 41 160 165 10.1002/ana.410410206
64. D Krige MT Carroll JM Cooper CD Marsden AH Schapira 1992 Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group Annals of Neurology 32 782 788 10.1002/ana.410320612
65. X Li T Burklen X Yuan U Schlattner DM Desiderio T Wallimann R Homayouni 2006 Stabilization of ubiquitous mitochondrial creatine kinase preprotein by APP family proteins Molecular and Cellular Neurosciences 31 263 272 10.1016/j.mcn.2005.09.015
66. AC Ludolph F He PS Spencer J Hammerstad M Sabri 1991 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin Canadian Journal of Neurological Sciences 18 492 498
67. AC Ludolph M Seelig AG Ludolph MI Sabri PS Spencer 1992 ATP deficits and neuronal degeneration induced by 3-nitropropionic acid Annals of the New York Academy of Sciences 648 300 302 10.1111/j.1749-6632.1992.tb24562.x
68. DJ Mahoney G Parise MA Tarnopolsky 2002 Nutritional and exercise-based therapies in the treatment of mitochondrial disease Current Opinion in Clinical Nutrition and Metabolic Care 5 619 629 10.1097/00075197-200211000-00004
69. WR Markesbery 1997 Oxidative stress hypothesis in Alzheimer's disease Free Radical Biology and Medicine 23 134 147 10.1016/S0891-5849(96)00629-6
70. RT Matthews L Yang BG Jenkins RJ Ferrante BR Rosen R Kaddurah-Daouk MF Beal 1998 Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease Journal of Neuroscience 18 156 163 (Pubitemid 28046777)
71. RT Matthews RJ Ferrante P Klivenyi L Yang AM Klein G Mueller R Kaddurah-Daouk MF Beal 1999 Creatine and cyclocreatine attenuate MPTP neurotoxicity Experimental Neurology 157 142 149 10.1006/exnr.1999.7049
72. I Maurer S Zierz HJ Moller 2000 A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients Neurobiology of Aging 21 455 462 10.1016/S0197-4580(00)00112-3
73. S Mihic JR MacDonald S McKenzie MA Tarnopolsky 2000 Acute creatine loading increases fat-free mass, but does not affect blood pressure, plasma creatinine, or CK activity in men and women Medicine and Science in Sports and Exercise 32 291 296 10.1097/00005768-200002000-00007 (Pubitemid 30108106)
74. NINDS NET-PD Investigators 2006 A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease Neurology 66 664 671 10.1212/01.wnl.0000201252.57661.e1
75. E O'Gorman T Piendl M Muller D Brdiczka T Wallimann 1997 Mitochondrial intermembrane inclusion bodies: The common denominator between human mitochondrial myopathies and creatine depletion, due to impairment of cellular energetics Molecular and Cellular Biochemistry 174 283 289 10.1023/A: 1006881113149
76. E O'Gorman G Beutner M Dolder AP Koretsky D Brdiczka T Wallimann 1997 The role of creatine kinase in inhibition of mitochondrial permeability transition FEBS Letters 414 253 257 10.1016/S0014-5793(97)01045-4
77. IG Onyango SM Khan 2006 Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease Current Alzheimer Research 3 339 349 10.2174/156720506778249489
78. S Palfi RJ Ferrante E Brouillet MF Beal R Dolan MC Guyot M Peschanski P Hantraye 1996 Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease Journal of Neuroscience 16 3019 3025 (Pubitemid 26121844)
79. WD Parker Jr SJ Boyson JK Parks 1989 Abnormalities of the electron transport chain in idiopathic Parkinson's disease Annals of Neurology 26 719 723 10.1002/ana.410260606
80. WD Parker Jr 1991 Cytochrome oxidase deficiency in Alzheimer's disease Annals of the New York Academy of Sciences 640 59 64
81. TI Peng JT Greenamyre 1998 Privileged access to mitochondria of calcium influx through N-methyl-d-aspartate receptors Molecular Pharmacology 53 974 980 (Pubitemid 28280438)
82. AM Persky GA Brazeau 2001 Clinical pharmacology of the dietary supplement creatine monohydrate Pharmacological Reviews 53 161 176 (Pubitemid 32476115)
83. JW Pettegrew K Panchalingam WE Klunk RJ McClure LR Muenz 1994 Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study Neurobiology of Aging 15 117 132 10.1016/0197-4580(94)90152-X (Pubitemid 24075020)
84. J Phukan NP Pender O Hardiman 2007 Cognitive impairment in amyotrophic lateral sclerosis Lancet Neurology 6 994 1003 10.1016/S1474-4422(07)70265-X
85. JR Poortmans H Auquier V Renaut A Durussel M Saugy GR Brisson 1997 Effect of short-term creatine supplementation on renal responses in men European Journal of Applied Physiology and Occupational Physiology 76 566 567 10.1007/s004210050291
86. JR Poortmans M Francaux 2000 Adverse effects of creatine supplementation: Fact or fiction? Sports Medicine 30 155 170 10.2165/00007256-200030030-00002 (Pubitemid 30707884)
87. AJ Primeau PJ Adhihetty DA Hood 2002 Apoptosis in heart and skeletal muscle Canadian Journal of Applied Physiology 27 349 395
88. C Rae AL Digney SR McEwan TC Bates 2003 Oral creatine monohydrate supplementation improves brain performance: A double-blind, placebo-controlled, cross-over trial Proceedings. Biological Sciences 270 2147 2150 10.1098/rspb.2003.2492
89. TM Robinson DA Sewell A Casey G Steenge PL Greenhaff 2000 Dietary creatine supplementation does not affect some haematological indices, or indices of muscle damage and hepatic and renal function British Journal of Sports Medicine 34 284 288 10.1136/bjsm.34.4.284
90. H Ryu RJ Ferrante 2005 Emerging chemotherapeutic strategies for Huntington's disease Expert Opinion on Emerging Drugs 10 345 363 10.1517/14728214.10.2.345
91. VA Saks LV Rosenshtraukh VN Smirnov EI Chazov 1978 Role of creatine phosphokinase in cellular function and metabolism Canadian Journal of Physiology and Pharmacology 56 691 706 (Pubitemid 9032124)
92. AH Schapira JM Cooper D Dexter JB Clark P Jenner CD Marsden 1990 Mitochondrial complex I deficiency in Parkinson's disease Journal of Neurochemistry 54 823 827 10.1111/j.1471-4159.1990.tb02325.x
93. U Schlattner M Tokarska-Schlattner T Wallimann 2006 Mitochondrial creatine kinase in human health and disease Biochimica et Biophysica Acta 1762 164 180 (Pubitemid 43006023)
94. JB Schulz MF Beal 1995 Neuroprotective effects of free radical scavengers and energy repletion in animal models of neurodegenerative disease Annals of the New York Academy of Sciences 765 100 110 10.1111/j.1749-6632.1995.tb16565.x
95. DJ Selkoe 1999 Translating cell biology into therapeutic advances in Alzheimer's disease Nature 399 A23 A31 10.1038/19866
96. JM Shefner ME Cudkowicz D Schoenfeld T Conrad J Taft M Chilton L Urbinelli M Qureshi H Zhang A Pestronk J Caress P Donofrio E Sorenson W Bradley C Lomen-Hoerth E Pioro K Rezania M Ross R Pascuzzi T Heiman-Patterson R Tandan H Mitsumoto J Rothstein T Smith-Palmer D MacDonald D Burke 2004 A clinical trial of creatine in ALS Neurology 63 1656 1661 (Pubitemid 39507584)
97. DK Simon DR Johns 1999 Mitochondrial disorders: Clinical and genetic features Annual Review of Medicine 50 111 127 10.1146/annurev.med.50.1.111
98. DH Small CA McLean 1999 Alzheimer's disease and the amyloid beta protein: What is the role of amyloid? Journal of Neurochemistry 73 443 449 10.1046/j.1471-4159.1999.0730443.x
99. CD Smith JM Carney PE Starke-Reed CN Oliver ER Stadtman RA Floyd WR Markesbery 1991 Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 88 10540 10543 10.1073/pnas.88.23.10540 (Pubitemid 21915871)
100. I Sora J Richman G Santoro H Wei Y Wang T Vanderah R Horvath M Nguyen S Waite WR Roeske 1994 The cloning and expression of a human creatine transporter Biochemical and Biophysical Research Communications 204 419 427 10.1006/bbrc.1994.2475
101. + responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies Cell 89 93 103 10.1016/S0092-8674(00) 80186-5 (Pubitemid 27180589)
102. GR Steenge J Lambourne A Casey IA Macdonald PL Greenhaff 1998 Stimulatory effect of insulin on creatine accumulation in human skeletal muscle American Journal of Physiology 275 E974 E979
103. S Stockler B Marescau PP De Deyn JM Trijbels F Hanefeld 1997 Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis Metabolism 46 1189 1193 10.1016/S0026-0495(97)90215-8
104. S Stockler F Hanefeld 1997 Guanidinoacetate methyltransferase deficiency: A newly recognized inborn error of creatine biosynthesis Wiener Klinische Wochenschrift 109 86 88 (Pubitemid 27105134)
105. F Streijger F Oerlemans BA Ellenbroek CR Jost B Wieringa CE Van Der Zee 2005 Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit Behavioural Brain Research 157 219 234 10.1016/j.bbr.2004.07.002
106. MA Tarnopolsky MF Beal 2001 Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders Annals of Neurology 49 561 574 10.1002/ana.1028
107. MA Tarnopolsky A Safdar 2008 The potential benefits of creatine and conjugated linoleic acid as adjuncts to resistance training in older adults Applied Physiology, Nutrition, and Metabolism 33 213 227 10.1139/H07-142
108. B Thomas MF Beal 2007 Parkinson's disease Human Molecular Genetics 16 Spec no. 2 R183 R194
109. J Valla JD Berndt F Gonzalez-Lima 2001 Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: Superficial laminar cytochrome oxidase associated with disease duration Journal of Neuroscience 21 4923 4930 (Pubitemid 32565651)
110. MS van der Knaap NM Verhoeven P Maaswinkel-Mooij PJ Pouwels W Onkenhout EA Peeters S Stockler-Ipsiroglu C Jakobs 2000 Mental retardation and behavioral problems as presenting signs of a creatine synthesis defect Annals of Neurology 47 540 543 10.1002/1531-8249(200004)47:4<540::AID-ANA23>3.0.CO;2-K
111. T Wallimann M Wyss D Brdiczka K Nicolay HM Eppenberger 1992 Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: The 'phosphocreatine circuit' for cellular energy homeostasis Biochemical Journal 281 Pt 1 21 40
112. T Wallimann W Hemmer 1994 Creatine kinase in non-muscle tissues and cells Molecular and Cellular Biochemistry 133-134 193 220 10.1007/BF01267955 (Pubitemid 24276833)
113. A Watanabe N Kato T Kato 2002 Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation Neuroscience Research 42 279 285 10.1016/S0168-0102(02)00007-X
114. P Weydt VV Pineda AE Torrence RT Libby TF Satterfield ER Lazarowski ML Gilbert GJ Morton TK Bammler AD Strand L Cui RP Beyer CN Easley AC Smith D Krainc S Luquet IR Sweet MW Schwartz AR La Spada 2006 Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration Cell Metabolism 4 349 362 10.1016/j.cmet.2006.10.004
115. PC Wong CA Pardo DR Borchelt MK Lee NG Copeland NA Jenkins SS Sisodia DW Cleveland DL Price 1995 An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria Neuron 14 1105 1116 10.1016/0896-6273(95)90259-7
116. M Wyss A Schulze 2002 Health implications of creatine: Can oral creatine supplementation protect against neurological and atherosclerotic disease? Neuroscience 112 243 260 10.1016/S0306-4522(02)00088-X
117. H Zong JM Ren LH Young M Pypaert J Mu MJ Birnbaum GI Shulman 2002 AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation Proceedings of the National Academy of Sciences of the United States of America 99 15983 15987 10.1073/pnas.252625599